Home
HelpTest Code TXPBU TOXICOLOGY PANEL AND BUPRENORPHINE WITH REFLEX TO CONFIRMATION, URINE
Performing Laboratory
NorDx Laboratories
Useful For
Screens for the following drugs/drug classes: amphetamines, barbiturates, benzodiazepines, cocaine metabolite, fentanyl, methadone, methadone metabolite, MDMA (Ecstasy), opiates, oxycodone, phencyclidine (PCP), propoxyphene, tetrahydrocannabinol (THC)
Positive test results are confirmed and/or quantitated at an additional charge.
This panel also screens for the presence of buprenorphine (an opiate) in urine by EIA at a cutoff concentration of 5 ng/mL. Positive results are confirmed and quantitated by LC-MS/MS at an additional charge.
Method Name
Cloned Enzyme Donor Immunoassay (CEDIA)
Enzyme Immunoassay (EIA)
Gas Chromatography-Mass Spectrometry (GC-MS) (If indicated)
Liquid Chromatography-Tandem Mass Spectrometry (LC-MC/MS) (If indicated)
Reference Values
Toxicology Profile: Not Detected
Screening Cutoff Concentration:
Amphetamines: 500 ng/mL
Barbiturates: 200 ng/mL
Benzodiazepines: 200 ng/mL
Buprenorphine: 5 ng/mL
Cocaine (benzoylecgonine – cocaine metabolite): 300 ng/mL
Fentanyl: 1 ng/mL
Methadone: 300 ng/mL
Methadone metabolite: 1000 ng/mL
MDMA: 500 ng/mL
Opiates: 300 ng/mL
Oxycodone: 100 ng/mL
Phencyclidine: 25 ng/mL
Propoxyphene: 300 ng/mL
Tetrahydrocannabinol carboxylic acid: 50 ng/mL
The presence of buprenorphine at 5 ng/mL or norbuprenorphine at 5 ng/mL is a strong indicator that the patient has used buprenorphine.
For help with interpretation please call: 877-323-0045
Please see test code BUPMT for additional buprenorphine confirmatory testing information.
Days and Times Test Performed
Monday through Friday
Report Available
1 Day
Specimen Type
Urine, Random
Preferred Container
Urine Cup
Preferred Volume
Urine, Random: 25 mL (Urine Cup)
Minimum Volume
Urine, Random: 10 mL (Urine Cup)
Specimen Collection and Handling
Collect random urine and send refrigerated in a clean, non-sterile urine container.
Specimen Stability Information
Specimen Type: Urine, Random
Frozen: 30 Days
Refrigerated: 7 Days
Add On Capable
Not Permitted
Advance Beneficiary Notice Requirements
This test, when ordered on Medicare patients, is subject to the National Coverage Determination (NCD) policies. Please verify that the diagnosis code (ICD code) you have chosen demonstrates medical necessity for the test as documented in the physician’s patient record. The CMS web site is available to assist you with this verification. A properly executed Advance Beneficiary Notice (ABN) must be submitted with the specimen if medical necessity is not demonstrated by the ICD code chosen.
CPT Code Information
|
CPT Code |
CPT Description |
CPT Disclaimer |
|---|---|---|
| 80307 | Drug Test, Presumptive Screening, By Instrument Chemistry (i.e Immunoassay, Chromatography, and Mass Spectrometry) | |
| 80326 | Amphetamines, 5 or more (Definitive Drug Testing), Quantitative | if Indicated |
| 80345 | Barbituates (Definitive), Quantitative | if Indicated |
| 80346 | Benzodiazepines, 1-12 (Definitive), Quantitative | if Indicated |
| 80348 | Buprenorphine (Definitive), Quantitative | if Indicated |
| 80349 | Cannibinoides, Natural (Definitive), Quantitative | if Indicated |
| 80353 | Cocaine (Definitive), Quantitative | if Indicated |
| 80354 | Fentanyl (Definitive), Quantitative | if Indicated |
| 80364 | Opioids and Opiate Analogs, 5 or more (Definitive), Quantitative | if Indicated |
| 80367 | Propoxyphene (Definitive), Quantitative | if Indicated |
| 83992 | Phencyclidine (PCP) (Definitive), Quantitative | if Indicated |
| G0480 | Drug Test (Definitive), 1-7 Classes | Government Payers, if Applicable |
| G0481 | Drug Test (Definitive), 8-14 Classes | Government Payers, if Applicable |
| G0482 | Drug Test (Definitive), 15-21 Classes | Government Payers, if Applicable |
| G0483 | Drug Test (Definitive), 22+ Classes | Government Payers, if Applicable |
Keywords
DRUGS OF ABUSE
Performing Laboratory Location
NorDx Laboratories
Maximum Laboratory Time
4 Days
Clinical Significance
Positive test results are confirmed and/or quantitated at an additional charge.
This test is intended for clinical monitoring and management of patients. It is not intended for non-medical use such as employment of forensic testing.
Specific gravity, pH, creatinine and oxidants will be performed and reported at no additional charge to identify potential adulteration of the urine specimen.
INTENDED POSITIVES:
Buprenorphine (Suboxone, Subutex)